Week37, 2023
1. Influenza activity remains low with 0.8% of respiratory specimens testing positive; 67.0% were Influenza A and 33.0% Influenza B in clinical laboratories.
2. Public health labs reported 49 positive specimens, with 73.5% Influenza A (majority H1N1) and 26.5% Influenza B (all Victoria lineage).
3. A novel Influenza A(H1N2)v virus infection was reported in Montana, linked to exposure at an agricultural fair; no person-to-person spread detected.
4. Hospital admissions for laboratory-confirmed influenza totaled 820 for week 37.
5. Mortality reports indicate 7.6% of PIC deaths exceeded the epidemic threshold, with influenza contributing to 13 deaths.
6. Outpatient ILI visits accounted for 2.0% of visits, with higher rates among children aged 0-4 (6.3%) and 5-24 (3.0%).
7. Pediatric influenza-associated deaths rose to a season total of 176, with 2 additional deaths recently reported.
8. CDC urges timely flu vaccinations, though no specific trends were highlighted in this report.
9. ILI activity across regions remains minimal to low, with localized variances due to co-circulating respiratory viruses.
10. Continued monitoring of novel influenza variants and subtypes is critical for early detection and management of potential outbreaks.